VSIR and ovarian cancer: Exclusion for immune cells, VISTA expresses higher in tumors and may interact with IGSF11 in immune regulation, including NSCLC [41], ovarian cancer [42], gastric cancer [43], colorectal cancer [44], soft tissue sarcoma [25] and oral squamous cell carcinoma [45].